Praxis director granted RSUs and stock options
Praxis Precision Medicines director Jeffrey Chodakewitz received new equity awards as part of his compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Praxis Precision Medicines director Jeffrey Chodakewitz received new equity awards as part of his compensation. He was granted 1,371 restricted stock units, each representing the right to receive one share of common stock, vesting in a single installment on the earlier of June 10, 2027 or the company’s 2027 annual stockholder meeting. He also received options for 648 shares at an exercise price of $240.66 per share, vesting in twelve equal monthly installments starting July 10, 2026 and expiring on June 10, 2036. These are awards from the company, not open-market purchases or sales.
Insider Trade Summary
Grant/Award: 2,019 shares
Grant/Award
2 txns
Insider
Chodakewitz Jeffrey
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 648 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,371 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 648 contracts (Direct);
Common Stock — 1,371 shares (Direct)
Footnotes (2)
- F1. Dr. Chodakewitz was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- F2. The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
Key Figures
Restricted stock units granted: 1,371 units
RSU vesting date: Earlier of June 10, 2027 or 2027 annual meeting
Options granted: 648 shares
+3 more
6 metrics
Restricted stock units granted
1,371 units
Award to Jeffrey Chodakewitz, each for one common share
RSU vesting date
Earlier of June 10, 2027 or 2027 annual meeting
Single installment vesting condition
Options granted
648 shares
Stock Option (Right to Buy) underlying common stock
Option exercise price
$240.66 per share
Conversion or exercise price for 648 options
Option vesting schedule start
July 10, 2026
First of twelve equal monthly installments
Option expiration date
June 10, 2036
Final date to exercise granted options
Key Terms
restricted stock units, Stock Option (Right to Buy), exercise price, annual meeting of stockholders, +1 more
5 terms
restricted stock units financial
"Dr. Chodakewitz was awarded 1,371 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price": "240.6600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual meeting of stockholders financial
"the date of the Issuer's 2027 annual meeting of stockholders."
vest financial
"The shares subject to this option shall vest in twelve (12) equal monthly installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Praxis Precision Medicines (PRAX) director Jeffrey Chodakewitz report on this Form 4?
Jeffrey Chodakewitz reported receiving equity awards from Praxis Precision Medicines, including restricted stock units and stock options. These are compensation-related grants, not open-market trades, and increase his potential future ownership in the company if vesting and settlement conditions are met.
How many restricted stock units did Jeffrey Chodakewitz receive from PRAX?
He received 1,371 restricted stock units from Praxis Precision Medicines. Each unit represents a contingent right to receive one share of common stock, with all units vesting together on a single future date tied to either June 10, 2027 or the 2027 annual meeting.
When do Jeffrey Chodakewitz’s PRAX restricted stock units vest?
The 1,371 restricted stock units vest in a single installment on the earlier of June 10, 2027 or the date of Praxis Precision Medicines’ 2027 annual meeting of stockholders. Once vested, they may be settled only by delivering shares of common stock.
What stock options did Jeffrey Chodakewitz receive from Praxis Precision Medicines (PRAX)?
He received options covering 648 shares of Praxis Precision Medicines common stock at an exercise price of $240.66 per share. These options vest in twelve equal monthly installments beginning July 10, 2026 and expire on June 10, 2036 if not exercised.
Are Jeffrey Chodakewitz’s PRAX equity awards open-market purchases or routine grants?
They are routine compensation grants, not open-market purchases. The Form 4 lists the transaction code as a grant or award acquisition, reflecting company-issued restricted stock units and stock options rather than discretionary buying or selling of existing shares.
How will the 648 PRAX stock options granted to Jeffrey Chodakewitz vest over time?
The 648 Praxis Precision Medicines stock options vest in twelve equal monthly installments. Vesting starts on July 10, 2026 and continues until the earlier of June 10, 2027 or the 2027 annual meeting, aligning vesting with the company’s annual governance cycle.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates